medigraphic.com
ISSN 2007-6800 (Print)

2017, Number 1

<< Back Next >>

Rev Mex Traspl 2017; 6 (1)

La referencia a trasplante renal en el IMSS: un área de oportunidad para la mejora

Méndez-Durán A, Ignorosa-Luna MH, Pérez-Aguilar G, Rivera-Rodríguez FJ, López-Ocaña LR

Language: Spanish
References: 16
Page: 29-33
PDF size: 211.70 Kb.


ABSTRACT

Introduction: Renal function therapies provide life support, but offer a high possibility of complications, and deterioration of quality and reduction of life expectancy. Renal transplantation grants the greatest rehabilitation, the possibility of a normal life, and family, social and labor reintegration. Objective: To identify the main characteristics of potential kidney recipients in the Mexican Social Security Institute over a period of two years. Material and methods: Retrospective and transverse two-year study, including references to renal transplantation of second level hospitals during 2014 and 2015. It did not include subjects older than 65 years of age. They were identified by delegation, gender, age group, cause of chronic renal failure (CRF), and status of dialysis therapy modality. Results: 5,484 patients were referred: 2,479 in 2014 and 3,005 in 2015; 3,369 were males (55%) and 2,115 females (45%). The frequency by age group was from four to 16 years (2%), from 17 to 27 (39%), from 28 to 38 (22%), from 39 to 49 (20%), from 50 to 59 (13%), and 60 years or older (4%). The reference showed an annual increase of 9.75% overall, 304 male cases (9%) and 222 female (10.5%). Jalisco was the delegation with greater reference in the two years, followed by Coahuila, Puebla and the Distrito Federal Norte; the majority of delegations showed an increase in the second year. Regarding the dialysis modality, the percentage of patients who underwent peritoneal dialysis was 56%, hemodialysis 37%, and pre-dialysis (7%). Throughout the period of study, the reference of patients of all modalities increased. Conclusions: The reference to renal transplantation shows a continuous increase; pre-dialysis patient become important and are referred more frequently. To benefit them, transplant surgery must be supported.


REFERENCES

  1. Centro Nacional de Trasplantes. Proceso de Donación. México: Secretaría de Salud; 2016. Disponible en: http://www.cenatra.salud.gob.mx/interior/donacion_procesos.html Consultado 4 de julio de 2016

  2. Solís-Vargas E, Evangelista-Carrillo LA, Puentes-Camacho A, Rojas-Campos E, Andrade-Sierra J, Gómez-Navarro B et al. Epidemiological characteristics of the largest kidney transplant program in Mexico: Western National Medical Center, Mexican Institute of Social Security. Transplant Proc. 2016; 48 (6): 1999-2005.

  3. Centro Nacional de Trasplantes. Estado actual de receptores, donación y trasplantes en México. 1.er trimestre, 2016. Disponible en: http://cenatra.salud.gob.mx/descargas/contenido/trasplante/1erSemestre2016.pdf

  4. Knoll G, Cockfield S, Blydt-Hansen T, Baran D, Kiberd B, Landsberg D et al. For the Kidney Transplant Working Group of the Canadian Society of Transplantation. Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ. 2005; 173 (10): 1181-1184.

  5. Lia Y, Lib J, Fub Q, Chenb L, Feib J, Dengb S et al. Kidney transplantation from brain-dead donors: initial experience in China. Transplant Proc. 2016; 48 (8): 2592-2595.

  6. Kroth LV, Barreiro FF, Saitovitch D, Traesel MA, D’Avila DO, Poli-de-Figueiredo CE. Kidney transplantation at a Southern Brazilian university hospital: a 35-year practice review. Transplant Proc. 2016; 48 (7): 2272-2275.

  7. Pruthi R, Casula A, MacPhee I. UK Renal Registry 15th annual report. Chapter 3: Demographic and biochemistry profile of kidney transplant recipients in the UK in 2011: national and centre-specific analyses. Nephron Clin Pract. 2013; 123: 55-80.

  8. Kramer A, Stel VS, Abad Diez J, De la Torre R, Bouzas CE, Čala S et al. Renal replacement therapy in Europe —a summary of the 2010 ERA-EDTA Registry Annual Report. Clin Kidney J. 2013; 6: 105-115.

  9. Reglamento de la Ley General de Salud en materia de trasplantes. Artículo 40. México: Secretaría de Salud; 2014.

  10. Carral NJ, Parellada BJ, Chávez PE. Problemática social de los trasplantes de órganos. Rev Cub Med Int Emerg. 2006; 5 (1): 322-327.

  11. Terner M, Redding N, Wu J. Increasing rates of kidney failure care in Canada strains demand for kidney donors. Healthc Q. 2016; 19 (3): 10-12.

  12. Molnar MZ, Mehrotra R, Duong U, Bunnapradist S, Lukowsky LR, Krishnan M et al. Dialysis modality and outcomes in kidney transplant recipients. Clin J Am Soc Nephrol. 2012; 7: 332-341.

  13. Lim HJ, Jambaldorj E, Lee Y, Kang SS, Koo TY, Ahn C et al. Increasing use of the expanded criteria for living kidney donation and good outcomes of living kidney donors in Korea. Transplant Proc. 2016; 48 (7): 2407-2411.

  14. Nemes B, Fedor R, Kanyári Z, Lösey L, Juhász F, Kovács DÁ et al. First outcomes, since being full member of Eurotransplant. A single center experience of cadaveric kidney transplantation. Orv Hetil. 2016; 157 (24): 925-937.

  15. Censo de Administración de Pacientes con Insuficiencia Renal Crónica (CIRC). Dirección de Prestaciones Médicas. Instituto Mexicano del Seguro Social; 2015.

  16. Informe anual de pacientes referidos a trasplante renal. División de Hospitales de Segundo Nivel. Dirección de Prestaciones Médicas. IMSS; 2015. Disponible en: http://cenatra.salud.gob.mx/informe_anual_2015.pdf




2020     |     www.medigraphic.com